Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 112

1.

Imaging beta-galactosidase activity in human tumor xenografts and transgenic mice using a chemiluminescent substrate.

Liu L, Mason RP.

PLoS One. 2010 Aug 6;5(8):e12024. doi: 10.1371/journal.pone.0012024.

2.

In vivo optical imaging of LacZ expression using lacZ transgenic mice.

Zhang GJ, Chen TB, Connolly B, Lin SA, Hargreaves R, Vanko A, Bednar B, Macneil DJ, Sur C, Williams DL.

Assay Drug Dev Technol. 2009 Aug;7(4):391-9. doi: 10.1089/adt.2009.0195.

PMID:
19689207
3.

Luminescent imaging of beta-galactosidase activity in living subjects using sequential reporter-enzyme luminescence.

Wehrman TS, von Degenfeld G, Krutzik PO, Nolan GP, Blau HM.

Nat Methods. 2006 Apr;3(4):295-301.

PMID:
16554835
4.

Novel S-Gal(®) analogs as (1)H MRI reporters for in vivo detection of β-galactosidase.

Gulaka PK, Yu JX, Liu L, Mason RP, Kodibagkar VD.

Magn Reson Imaging. 2013 Jul;31(6):1006-11. doi: 10.1016/j.mri.2013.03.001. Epub 2013 Apr 18.

6.

lacZ as a genetic reporter for real-time MRI.

Bengtsson NE, Brown G, Scott EW, Walter GA.

Magn Reson Med. 2010 Mar;63(3):745-53. doi: 10.1002/mrm.22235.

7.

β-Galactosidase staining of lacZ fusion proteins in whole tissue preparations.

Cooper MA, Zhou R.

Methods Mol Biol. 2013;1018:189-97. doi: 10.1007/978-1-62703-444-9_18.

PMID:
23681629
8.

In vivo imaging of beta-galactosidase activity using far red fluorescent switch.

Tung CH, Zeng Q, Shah K, Kim DE, Schellingerhout D, Weissleder R.

Cancer Res. 2004 Mar 1;64(5):1579-83.

9.

Non-invasive in vivo optical imaging of the lacZ and luc gene expression in mice.

Josserand V, Texier-Nogues I, Huber P, Favrot MC, Coll JL.

Gene Ther. 2007 Nov;14(22):1587-93. Epub 2007 Sep 20.

PMID:
17882264
10.

Enhanced detection of beta-galactosidase reporter activation is achieved by a reduction of hemoglobin content in tissue lysates.

Nazarenko DA, Dertinger SD, Gasiewicz TA.

Biotechniques. 2001 Apr;30(4):776-7, 780-1.

PMID:
11314260
11.

Imaging beta-galactosidase activity in vivo using sequential reporter-enzyme luminescence.

von Degenfeld G, Wehrman TS, Blau HM.

Methods Mol Biol. 2009;574:249-59. doi: 10.1007/978-1-60327-321-3_20.

12.

A 19F-NMR approach using reporter molecule pairs to assess beta-galactosidase in human xenograft tumors in vivo.

Yu JX, Kodibagkar VD, Liu L, Mason RP.

NMR Biomed. 2008 Aug;21(7):704-12. doi: 10.1002/nbm.1244.

13.

False-positive beta-galactosidase staining in osteoclasts by endogenous enzyme: studies in neonatal and month-old wild-type mice.

Odgren PR, MacKay CA, Mason-Savas A, Yang M, Mailhot G, Birnbaum MJ.

Connect Tissue Res. 2006;47(4):229-34.

PMID:
16987755
14.

Targeting of lacZ reporter gene expression with radioiodine-labelled phenylethyl-beta- d-thiogalactopyranoside.

Lee KH, Byun SS, Choi JH, Paik JY, Choe YS, Kim BT.

Eur J Nucl Med Mol Imaging. 2004 Mar;31(3):433-8. Epub 2004 Jan 27.

PMID:
14745516
15.
16.

Positron emission tomography-based imaging of transgene expression mediated by replication-conditional, oncolytic herpes simplex virus type 1 mutant vectors in vivo.

Jacobs A, Tjuvajev JG, Dubrovin M, Akhurst T, Balatoni J, Beattie B, Joshi R, Finn R, Larson SM, Herrlinger U, Pechan PA, Chiocca EA, Breakefield XO, Blasberg RG.

Cancer Res. 2001 Apr 1;61(7):2983-95.

17.

A fast and sensitive alternative for β-galactosidase detection in mouse embryos.

Sundararajan S, Wakamiya M, Behringer RR, Rivera-Pérez JA.

Development. 2012 Dec 1;139(23):4484-90. doi: 10.1242/dev.078790.

20.

Optical imaging of targeted β-galactosidase in brain tumors to detect EGFR levels.

Broome AM, Ramamurthy G, Lavik K, Liggett A, Kinstlinger I, Basilion J.

Bioconjug Chem. 2015 Apr 15;26(4):660-8. doi: 10.1021/bc500597y. Epub 2015 Mar 30.

Supplemental Content

Support Center